Tales From the AACR’s Immunotherapy Conference
Guest Post by T.J. Sharpe Originally appeared on Philly.com's Patient #1 blog
Guest Post by T.J. Sharpe Originally appeared on Philly.com's Patient #1 blog
Rarely do investigators in two distinct fields of cancer research have the time to come together for an evening...
Yesterday, the U.S. Food and Drug Administration (FDA) announced the highly anticipated approval of the cancer immunotherapeutic pembrolizumab (Keytruda)...
What is cancer immunotherapy, how does it work, and why are people so excited about it?
When I was a child, the proximity of the Jersey Shore to my hometown made the beach a frequent...